1H-Quinazoline-2,4-diones and their use as AMPA-receptor ligands

Details for Australian Patent Application No. 2006233639 (hide)

Owner Novartis AG

Inventors Allgeier, Hans; Nozulak, Joachim; Kallen, Jorg; Mattes, Henri; Guibourdenche, Christel; Carcache, David; Floersheim, Philipp; Froestl, Wolfgang; Auberson, Yves; Koller, Manuel; Orain, David; Renaud, Johanne

Agent Davies Collison Cave

Pub. Number AU-B-2006233639

PCT Pub. Number WO2006/108591

Priority 0507298.8 11.04.05 GB

Filing date 10 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 9 December 2010

International Classifications

C07D 239/96 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07C 229/56 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 229/64 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 229/66 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 255/18 (2006.01) Carboxylic acid nitriles

C07C 265/12 (2006.01) Derivatives of isocyanic acid

C07D 207/32 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/337 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 237/08 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 239/26 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 241/12 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 307/16 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/54 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 309/12 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/108591 Priority application(s): WO2006/108591

9 December 2010 Application Accepted

  Published as AU-B-2006233639

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233640-Instant product

2006233638-Modified coagulation Factor VIII with enhanced stability and its derivates